Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Overview
Date Founded

1971

Headquarters

900 Ridgebury Road,Ridgefield, CT 06877

Type of Company

Private

Employees (Worldwide)

1,796

Industries

Pharmaceuticals

Company Description

Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.

Website

http://www.boehringer-ingelheim.us

Contact Data
Trying to get in touch with decision makers at Boehringer Ingelheim Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
January 21, 2021
Global Antiretroviral Therapy Market Outlook to 2024, Featuring Company Profiles of Key Players Gilead Sciences, GSK, Roche Holding, Boehringer Ingelheim, Cipla and Abbvie
PR Newswire
January 18, 2021
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
ENP Newswire
January 14, 2021
-Boehringer Ingelheim receives EMA marketing authorization for NexGard COMBO, the first isoxazoline-based full endectocide for cats
Targeted News Service
January 13, 2021
Case Western Reserve University Teams With Boehringer Ingelheim on Artificial Intelligence Solutions for Precision Medicine
Marketline Newswire
January 13, 2021
Boehringer enters into cancer drug development deal with Enara Bio

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Hemal Shah

Executive Director

Veronika Kohlbrenner

Executive Director

William Tunno

Head of Global Oncology, Patient Advocacy & Professional Relations

Norbert Kraut

Global Head & Vice President, Cancer Research

Diane Larsen

Head, Global Development Projects

Ann Wainright

Head-Public Relations

Kevin G. Lokay

Vice President & Business Unit Head, Oncology

Zinta Krumins

Managing Director

Anna Verbeek

Director of Clinical Development & Medical Affairs

Monica Uhlenberg

Director

Trending People
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Trending Organizations
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Paths to Boehringer Ingelheim Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Boehringer Ingelheim Pharmaceuticals, Inc.
Transaction Advisors
Legal Advisor
Kirkland & Ellis LLP

Advised onHikma Pharmaceuticals Plc purchases Roxane Laboratories, Inc. from C.H. Boehringer Sohn AG & Co. KG

Investment Advisor
Morgan Stanley & Co. LLC

Advised onHikma Pharmaceuticals Plc purchases Roxane Laboratories, Inc. from C.H. Boehringer Sohn AG & Co. KG

Advisors & Consultants
Legal Advisor
Wick Sollers

Partner at King & Spalding LLP

Advisor
Paul Fonteyne

Director at Ypsomed Holding AG

Legal Advisor
Peter Carney

Partner at White & Case LLP
Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$296M
Non-Profit Donations & Grants
$100K +
2019
Copd Foundation, Inc.

$1,000 +
2019
University of Pittsburgh - Pittsburgh

$500 +
2019
Cancer Care, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Boehringer Ingelheim Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Boehringer Ingelheim Pharmaceuticals, Inc..